159 related articles for article (PubMed ID: 15291033)
21. Gene Therapy for ALS: progress and prospects.
Azzouz M
Biochim Biophys Acta; 2006; 1762(11-12):1122-7. PubMed ID: 16806843
[TBL] [Abstract][Full Text] [Related]
22. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
[TBL] [Abstract][Full Text] [Related]
23. A lentiviral strategy for highly efficient retrograde gene transfer by pseudotyping with fusion envelope glycoprotein.
Kato S; Kobayashi K; Inoue K; Kuramochi M; Okada T; Yaginuma H; Morimoto K; Shimada T; Takada M; Kobayashi K
Hum Gene Ther; 2011 Feb; 22(2):197-206. PubMed ID: 20954846
[TBL] [Abstract][Full Text] [Related]
24. Comparative analysis of HIV-1-based lentiviral vectors bearing lyssavirus glycoproteins for neuronal gene transfer.
Federici T; Kutner R; Zhang XY; Kuroda H; Tordo N; Boulis NM; Reiser J
Genet Vaccines Ther; 2009 Jan; 7():1. PubMed ID: 19144125
[TBL] [Abstract][Full Text] [Related]
25. RNAi therapy: dominant disease gene gets silenced.
Xu Z; Xia XG
Gene Ther; 2005 Aug; 12(15):1159-60. PubMed ID: 15858609
[No Abstract] [Full Text] [Related]
26. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis.
Ripps ME; Huntley GW; Hof PR; Morrison JH; Gordon JW
Proc Natl Acad Sci U S A; 1995 Jan; 92(3):689-93. PubMed ID: 7846037
[TBL] [Abstract][Full Text] [Related]
27. Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS.
Raoul C; Abbas-Terki T; Bensadoun JC; Guillot S; Haase G; Szulc J; Henderson CE; Aebischer P
Nat Med; 2005 Apr; 11(4):423-8. PubMed ID: 15768028
[TBL] [Abstract][Full Text] [Related]
28. Increased survival and function of SOD1 mice after glial cell-derived neurotrophic factor gene therapy.
Acsadi G; Anguelov RA; Yang H; Toth G; Thomas R; Jani A; Wang Y; Ianakova E; Mohammad S; Lewis RA; Shy ME
Hum Gene Ther; 2002 Jun; 13(9):1047-59. PubMed ID: 12067438
[TBL] [Abstract][Full Text] [Related]
29. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model.
Kaspar BK; Lladó J; Sherkat N; Rothstein JD; Gage FH
Science; 2003 Aug; 301(5634):839-42. PubMed ID: 12907804
[TBL] [Abstract][Full Text] [Related]
30. The lack of effect of specific overexpression of IGF-1 in the central nervous system or skeletal muscle on pathophysiology in the G93A SOD-1 mouse model of ALS.
Messi ML; Clark HM; Prevette DM; Oppenheim RW; Delbono O
Exp Neurol; 2007 Sep; 207(1):52-63. PubMed ID: 17597610
[TBL] [Abstract][Full Text] [Related]
31. Widespread and efficient transduction of spinal cord and brain following neonatal AAV injection and potential disease modifying effect in ALS mice.
Ayers JI; Fromholt S; Sinyavskaya O; Siemienski Z; Rosario AM; Li A; Crosby KW; Cruz PE; DiNunno NM; Janus C; Ceballos-Diaz C; Borchelt DR; Golde TE; Chakrabarty P; Levites Y
Mol Ther; 2015 Jan; 23(1):53-62. PubMed ID: 25228069
[TBL] [Abstract][Full Text] [Related]
32. Early and selective pathology of light chain neurofilament in the spinal cord and sciatic nerve of G86R mutant superoxide dismutase transgenic mice.
Morrison BM; Shu IW; Wilcox AL; Gordon JW; Morrison JH
Exp Neurol; 2000 Oct; 165(2):207-20. PubMed ID: 10993681
[TBL] [Abstract][Full Text] [Related]
33. Local GDNF expression mediated by lentiviral vector protects facial nerve motoneurons but not spinal motoneurons in SOD1(G93A) transgenic mice.
Guillot S; Azzouz M; Déglon N; Zurn A; Aebischer P
Neurobiol Dis; 2004 Jun; 16(1):139-49. PubMed ID: 15207271
[TBL] [Abstract][Full Text] [Related]
34. Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA.
Wang J; Xu G; Slunt HH; Gonzales V; Coonfield M; Fromholt D; Copeland NG; Jenkins NA; Borchelt DR
Neurobiol Dis; 2005 Dec; 20(3):943-52. PubMed ID: 16046140
[TBL] [Abstract][Full Text] [Related]
35. Positive effect of transplantation of hNT neurons (NTera 2/D1 cell-line) in a model of familial amyotrophic lateral sclerosis.
Garbuzova-Davis S; Willing AE; Milliken M; Saporta S; Zigova T; Cahill DW; Sanberg PR
Exp Neurol; 2002 Apr; 174(2):169-80. PubMed ID: 11922659
[TBL] [Abstract][Full Text] [Related]
36. Gene therapy for amyotrophic lateral sclerosis and other motor neuron diseases.
Alisky JM; Davidson BL
Hum Gene Ther; 2000 Nov; 11(17):2315-29. PubMed ID: 11096437
[TBL] [Abstract][Full Text] [Related]
37. Increased phospho-adducin immunoreactivity in a murine model of amyotrophic lateral sclerosis.
Shan X; Hu JH; Cayabyab FS; Krieger C
Neuroscience; 2005; 134(3):833-46. PubMed ID: 15994023
[TBL] [Abstract][Full Text] [Related]
38. Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS.
Hall ED; Andrus PK; Oostveen JA; Fleck TJ; Gurney ME
J Neurosci Res; 1998 Jul; 53(1):66-77. PubMed ID: 9670993
[TBL] [Abstract][Full Text] [Related]
39. Lentiviral vectors enveloped with rabies virus glycoprotein can be used as a novel retrograde tracer to assess nerve recovery in rat sciatic nerve injury models.
Wei Y; Gong K; Ao Q; Wang A; Gong Y; Zuo H; Zhang Y; Wang J; Wang G
Cell Tissue Res; 2014 Feb; 355(2):255-66. PubMed ID: 24326614
[TBL] [Abstract][Full Text] [Related]
40. Altered sensorimotor development in a transgenic mouse model of amyotrophic lateral sclerosis.
Amendola J; Verrier B; Roubertoux P; Durand J
Eur J Neurosci; 2004 Nov; 20(10):2822-6. PubMed ID: 15548226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
